Share Price, page-8469

I will say something though against a takeover.
Something has just been poking me in ribs for a couple of months where Jon discussed Trof and NNZ2591.

it was that there’s not enough investment in Bio’s in this country.
Not his direct words here, but that they believe they know enough to proceed with 2591 a lot faster than what trof took.

he thought trof took too long.
But here’s the poking in ribs bit.

he said that you only get true value when you control the drug all the way to market.

let’s not forget, he has 400,000 shares.